Atlas Trials

A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male Subjects

Clinical trial NCT02497924 · COMPLETED

Trial details

NCT number
NCT02497924
Sponsor
Global Blood Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Anemia, Sickle Cell
Start date
2015-06-01
Primary completion
2016-07-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.